• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶在前列腺癌中的靶向治疗。

Matrix metalloproteinases targeting in prostate cancer.

机构信息

Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, PR China.

State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China.

出版信息

Urol Oncol. 2024 Sep;42(9):275-287. doi: 10.1016/j.urolonc.2024.05.002. Epub 2024 May 28.

DOI:10.1016/j.urolonc.2024.05.002
PMID:38806387
Abstract

Prostate cancer (PCa) is one of the most common tumors affecting men all over the world. PCa has brought a huge health burden to men around the world, especially for elderly men, but its pathogenesis is unclear. In prostate cancer, epigenetic inheritance plays an important role in the development, progression, and metastasis of the disease. An important role in cancer invasion and metastasis is played by matrix metalloproteinases (MMPs), zinc-dependent proteases that break down extracellular matrix. We review two important forms of epigenetic modification and the role of matrix metalloproteinases in tumor regulation, both of which may be of significant value as novel biomarkers for early diagnosis and prognosis monitoring. The author considers that both mechanisms have promising therapeutic applications for therapeutic agent research in prostate cancer, but that efforts should be made to mitigate or eliminate the side effects of drug therapy in order to maximize quality of life of patients. The understanding of epigenetic modification, MMPs, and their inhibitors in the functional regulation of prostate cancer is gradually advancing, it will provide a new technical means for the prevention of prostate cancer, early diagnosis, androgen-independent prostate cancer treatment, and drug research.

摘要

前列腺癌(PCa)是全世界男性最常见的肿瘤之一。PCa 给全世界的男性带来了巨大的健康负担,尤其是老年男性,但它的发病机制尚不清楚。在前列腺癌中,表观遗传遗传在疾病的发生、发展和转移中起着重要作用。基质金属蛋白酶(MMPs)在癌症的侵袭和转移中起着重要作用,MMPs 是一种锌依赖性蛋白酶,可分解细胞外基质。我们回顾了两种重要的表观遗传修饰形式和基质金属蛋白酶在肿瘤调控中的作用,这两者都可能作为早期诊断和预后监测的新型生物标志物具有重要价值。作者认为,这两种机制都为前列腺癌的治疗药物研究提供了有前途的治疗应用,但应努力减轻或消除药物治疗的副作用,以最大限度地提高患者的生活质量。对表观遗传修饰、MMPs 及其抑制剂在前列腺癌功能调控中的认识正在逐步深入,这将为前列腺癌的预防、早期诊断、雄激素非依赖性前列腺癌治疗和药物研究提供新的技术手段。

相似文献

1
Matrix metalloproteinases targeting in prostate cancer.基质金属蛋白酶在前列腺癌中的靶向治疗。
Urol Oncol. 2024 Sep;42(9):275-287. doi: 10.1016/j.urolonc.2024.05.002. Epub 2024 May 28.
2
Matrix Metalloproteinases: A challenging paradigm of cancer management.基质金属蛋白酶:癌症管理极具挑战性的范例。
Semin Cancer Biol. 2019 Jun;56:100-115. doi: 10.1016/j.semcancer.2017.11.008. Epub 2017 Nov 16.
3
The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer.基质金属蛋白酶在前列腺癌中的预后价值及其潜在机制。
Int J Med Sci. 2020 Jun 21;17(11):1550-1560. doi: 10.7150/ijms.46780. eCollection 2020.
4
Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression.基质金属蛋白酶在神经内分泌前列腺癌的发生、转移和血管生成进展中发挥不同的作用。
Cancer Res. 2010 Mar 15;70(6):2224-34. doi: 10.1158/0008-5472.CAN-09-3515. Epub 2010 Mar 9.
5
Regulation of Matrix Metalloproteinase in the Pathogenesis of Diabetic Retinopathy.基质金属蛋白酶在糖尿病视网膜病变发病机制中的调控
Prog Mol Biol Transl Sci. 2017;148:67-85. doi: 10.1016/bs.pmbts.2017.02.004. Epub 2017 Mar 14.
6
Pharmacodynamic considerations in the use of matrix metalloproteinase inhibitors in cancer treatment.基质金属蛋白酶抑制剂在癌症治疗中的药效学考量
Expert Opin Drug Metab Toxicol. 2016;12(2):191-200. doi: 10.1517/17425255.2016.1131820. Epub 2016 Jan 11.
7
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.金属蛋白酶及其抑制剂:开发新型治疗药物的潜力。
Cells. 2020 May 25;9(5):1313. doi: 10.3390/cells9051313.
8
Seesaw of matrix metalloproteinases (MMPs).基质金属蛋白酶(MMPs)的跷跷板效应
J Cancer Res Ther. 2016 Jan-Mar;12(1):28-35. doi: 10.4103/0973-1482.157337.
9
Matrix Metalloproteinases in Oral Cancer Pathogenesis and their Use in Therapy.口腔癌发病机制中的基质金属蛋白酶及其在治疗中的应用。
Anticancer Agents Med Chem. 2024;24(1):3-17. doi: 10.2174/0118715206270002231108071917.
10
Is there new hope for therapeutic matrix metalloproteinase inhibition?治疗性基质金属蛋白酶抑制有新希望吗?
Nat Rev Drug Discov. 2014 Dec;13(12):904-27. doi: 10.1038/nrd4390. Epub 2014 Nov 7.

引用本文的文献

1
: Phytochemical Composition, Antioxidant and Anti-Cancerous Bioactivities on Triple-Negative Breast Cancer Cells.植物化学成分、抗氧化及对三阴性乳腺癌细胞的抗癌生物活性
Int J Mol Sci. 2025 Sep 1;26(17):8506. doi: 10.3390/ijms26178506.
2
Landscape analysis of matrix metalloproteinases reveals key prognostic markers for prostate cancer.基质金属蛋白酶的景观分析揭示了前列腺癌的关键预后标志物。
Front Immunol. 2025 Jun 18;16:1582992. doi: 10.3389/fimmu.2025.1582992. eCollection 2025.
3
Assessment of the effect of pomegranate seed extracts on prostate cancer through cellular and animal models.
通过细胞和动物模型评估石榴籽提取物对前列腺癌的影响。
Sci Rep. 2025 Jul 1;15(1):20379. doi: 10.1038/s41598-025-07910-w.
4
Identification of prostate cancer potential therapeutic targets and virtual drug screening through combined Mendelian randomization study, Bayesian colocalization and molecular docking.通过孟德尔随机化研究、贝叶斯共定位和分子对接联合鉴定前列腺癌潜在治疗靶点及虚拟药物筛选
Discov Oncol. 2025 Jun 18;16(1):1149. doi: 10.1007/s12672-025-02968-4.
5
Circulating innate lymphoid cells are dysregulated in patients with prostate cancer.前列腺癌患者体内循环的固有淋巴细胞失调。
Cell Mol Biol Lett. 2025 Apr 18;30(1):48. doi: 10.1186/s11658-025-00725-7.
6
circDHX33 suppresses glycolysis, malignant proliferation, and metastasis in prostate cancer by interacting with RNA-binding protein IGF2BP2 to destabilize its protein.环状DHX33通过与RNA结合蛋白IGF2BP2相互作用使该蛋白不稳定,从而抑制前列腺癌中的糖酵解、恶性增殖和转移。
Cytotechnology. 2025 Apr;77(2):56. doi: 10.1007/s10616-025-00718-6. Epub 2025 Feb 6.
7
Predictive diagnostic value of mean platelet volume to platelet count and neutrophil to lymphocyte ratios in the gray zone of prostate cancer with tPSA between 4 to 10 ng/mL.总前列腺特异抗原(tPSA)在4至10 ng/mL之间的前列腺癌灰色区域中,平均血小板体积与血小板计数及中性粒细胞与淋巴细胞比值的预测诊断价值。
Front Oncol. 2024 Oct 14;14:1454124. doi: 10.3389/fonc.2024.1454124. eCollection 2024.
8
Evidence of the Link between Stroma Remodeling and Prostate Cancer Prognosis.基质重塑与前列腺癌预后之间联系的证据。
Cancers (Basel). 2024 Sep 21;16(18):3215. doi: 10.3390/cancers16183215.